• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

290 - 342盐桥的破坏并非PiZ α1 - 抗胰蛋白酶变体分泌缺陷的原因。

Disruption of the 290-342 salt bridge is not responsible for the secretory defect of the PiZ alpha 1-antitrypsin variant.

作者信息

Sifers R N, Hardick C P, Woo S L

机构信息

Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas 77030.

出版信息

J Biol Chem. 1989 Feb 15;264(5):2997-3001.

PMID:2563374
Abstract

Crystallographic studies have previously suggested that Lys290 forms a salt bridge with Glu342 in the serine protease inhibitor alpha 1-antitrypsin. Disruption of the formation of this structural feature by a Glu to Lys substitution at residue 342 in the PiZ variant has been implicated in causing the defective secretion of this mutant protein from hepatocytes (10-15% of normal). To test the validity of this hypothesis, mutant human alpha 1-antitrypsin cDNA constructs coding for specific amino acid substitutions at residues 290 and 342 were generated and the corresponding mutant proteins were expressed in mouse hepatoma cells. When the potential to form the salt bridge was reestablished by a Lys290 to Glu290 substitution in the PiZ variant, its secretion was increased to only 38% of normal. Furthermore, disruption of this structural feature by a Lys290 to Glu290 substitution in the normal inhibitor failed to reduce the secretion of alpha 1-antitrypsin to the extent observed for the PiZ variant (73% of normal). Finally, substitution of the neutral amino acid Gln at residue 342 only reduced the secretion of alpha 1-antitrypsin to 55% of normal. Of all mutant proteins tested, those bearing Lys at position 342 were secreted at the lowest levels. These findings demonstrate that although disruption of the 290-342 salt bridge does affect the secretion of alpha 1-antitrypsin, it is the substitution of Lys at residue 342 that causes the dramatic secretory defect of the PiZ variant.

摘要

晶体学研究先前表明,在丝氨酸蛋白酶抑制剂α1-抗胰蛋白酶中,赖氨酸290与谷氨酸342形成盐桥。在PiZ变体中,第342位残基处的谷氨酸被赖氨酸取代,破坏了这种结构特征的形成,这被认为是导致该突变蛋白从肝细胞分泌缺陷(为正常水平的10 - 15%)的原因。为了验证这一假设,构建了编码第290位和342位残基处特定氨基酸取代的突变型人α1-抗胰蛋白酶cDNA,并在小鼠肝癌细胞中表达相应的突变蛋白。当通过在PiZ变体中将赖氨酸290替换为谷氨酸290来重建形成盐桥的可能性时,其分泌量仅增加到正常水平的38%。此外,在正常抑制剂中通过将赖氨酸290替换为谷氨酸290来破坏这种结构特征,并没有将α1-抗胰蛋白酶的分泌减少到PiZ变体所观察到的程度(为正常水平的73%)。最后,在第342位残基处替换为中性氨基酸谷氨酰胺,仅将α1-抗胰蛋白酶的分泌减少到正常水平的55%。在所有测试的突变蛋白中,第342位带有赖氨酸的那些蛋白分泌水平最低。这些发现表明,虽然290 - 342盐桥的破坏确实会影响α1-抗胰蛋白酶的分泌,但正是第342位残基处赖氨酸的取代导致了PiZ变体显著的分泌缺陷。

相似文献

1
Disruption of the 290-342 salt bridge is not responsible for the secretory defect of the PiZ alpha 1-antitrypsin variant.290 - 342盐桥的破坏并非PiZ α1 - 抗胰蛋白酶变体分泌缺陷的原因。
J Biol Chem. 1989 Feb 15;264(5):2997-3001.
2
Disruption of the Lys-290--Glu-342 salt bridge in human alpha 1-antitrypsin does not prevent its synthesis and secretion.
FEBS Lett. 1987 May 25;216(1):79-82. doi: 10.1016/0014-5793(87)80760-3.
3
Repair of the secretion defect in the Z form of alpha 1-antitrypsin by addition of a second mutation.
Science. 1988 Dec 23;242(4886):1700-2. doi: 10.1126/science.2904702.
4
Intracellular degradation of the transport-impaired human PiZ alpha 1-antitrypsin variant. Biochemical mapping of the degradative event among compartments of the secretory pathway.
J Biol Chem. 1990 Aug 15;265(23):14001-7.
5
Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.PiZα1-抗胰蛋白酶的积累会导致转基因小鼠肝脏损伤。
J Clin Invest. 1989 Apr;83(4):1183-90. doi: 10.1172/JCI113999.
6
Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342.人α1-蛋白酶抑制剂Z变体分泌缺陷的分子基础:氨基酸290和342之间盐桥形成潜力改变的变体的分泌
Mol Cell Biol. 1989 Apr;9(4):1406-14. doi: 10.1128/mcb.9.4.1406-1414.1989.
7
Expression of PiM-and PiZ-mutated forms of the human alpha 1-antitrypsin gene in transfected monkey COS1 cells.人α1-抗胰蛋白酶基因的PiM和PiZ突变形式在转染的猴COS1细胞中的表达
J Biol Chem. 1990 Dec 25;265(36):22153-8.
8
Intracellular retention and degradation of human mutant variant of a alpha 1-antitrypsin in stably transfected Chinese hamster ovary cell lines.人α1-抗胰蛋白酶突变体在稳定转染的中国仓鼠卵巢细胞系中的细胞内滞留与降解
Eur J Biochem. 1993 Apr 1;213(1):271-6. doi: 10.1111/j.1432-1033.1993.tb17759.x.
9
Correcting the PiZ defect in the alpha 1-antitrypsin gene of human cells by targeted homologous recombination.通过靶向同源重组纠正人类细胞α1-抗胰蛋白酶基因中的PiZ缺陷。
Lab Invest. 1994 May;70(5):676-83.
10
BiP expression is not increased by the accumulation of PiZ alpha 1-antitrypsin in the endoplasmic reticulum.
FEBS Lett. 1990 Jul 16;267(2):277-80. doi: 10.1016/0014-5793(90)80944-e.

引用本文的文献

1
Successes and challenges in simulating the folding of large proteins.模拟大型蛋白质折叠的成功与挑战。
J Biol Chem. 2020 Jan 3;295(1):15-33. doi: 10.1074/jbc.REV119.006794. Epub 2019 Nov 11.
2
Patient-Derived Induced Pluripotent Stem Cells for Alpha-1 Antitrypsin Deficiency Disease Modeling and Therapeutic Discovery.用于α-1抗胰蛋白酶缺乏症疾病建模和治疗发现的患者来源诱导多能干细胞
Chronic Obstr Pulm Dis. 2018 Sep 15;5(4):258-266. doi: 10.15326/jcopdf.5.4.2017.0179.
3
All-Atom Simulations Reveal How Single-Point Mutations Promote Serpin Misfolding.
全原子模拟揭示单点突变如何促进丝氨酸蛋白酶抑制剂错误折叠。
Biophys J. 2018 May 8;114(9):2083-2094. doi: 10.1016/j.bpj.2018.03.027.
4
SVIP regulates Z variant alpha-1 antitrypsin retro-translocation by inhibiting ubiquitin ligase gp78.SVIP通过抑制泛素连接酶gp78来调节Z变体α-1抗胰蛋白酶的逆向转运。
PLoS One. 2017 Mar 16;12(3):e0172983. doi: 10.1371/journal.pone.0172983. eCollection 2017.
5
Contributions of the Lectin and Polypeptide Binding Sites of Calreticulin to Its Chaperone Functions in Vitro and in Cells.钙网蛋白的凝集素和多肽结合位点对其在体外和细胞中的伴侣功能的贡献。
J Biol Chem. 2016 Sep 9;291(37):19631-41. doi: 10.1074/jbc.M116.746321. Epub 2016 Jul 13.
6
Molecular Mechanism of Z α1-Antitrypsin Deficiency.Zα1-抗胰蛋白酶缺乏症的分子机制
J Biol Chem. 2016 Jul 22;291(30):15674-86. doi: 10.1074/jbc.M116.727826. Epub 2016 May 31.
7
Conformational properties of the disease-causing Z variant of α1-antitrypsin revealed by theory and experiment.理论和实验揭示致病变异型α1-抗胰蛋白酶的构象特性。
Biophys J. 2012 Jun 20;102(12):2856-65. doi: 10.1016/j.bpj.2012.05.023. Epub 2012 Jun 19.
8
Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease.在纯合子PiZZα1抗胰蛋白酶缺乏症和肝病患者中,应激蛋白的合成增加。
J Clin Invest. 1989 Nov;84(5):1555-61. doi: 10.1172/JCI114332.
9
Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease.分子生物学与呼吸系统疾病。7. α1抗胰蛋白酶基因与慢性肺病。
Thorax. 1990 Oct;45(10):759-64. doi: 10.1136/thx.45.10.759.
10
Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.α1-抗胰蛋白酶缺乏症、肺气肿与肝脏疾病。遗传基础及治疗策略。
J Clin Invest. 1990 May;85(5):1343-52. doi: 10.1172/JCI114578.